A new "effective" Alzheimer's drug has been rejected for widespread use in the NHS in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”.
Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...
Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly and silently appears to lay the groundwork for a second, more widely ...
What Causes Alzheimer’s Disease? Researchers don't know exactly what causes Alzheimer’s disease. Many things are thought to be involved. But as scientists have learned more about the condition ...
Oct. 15, 2024 — Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools. According to researchers who discovered this new ...
In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback